
Overview
I focus on treating patients with blood cancers who are considering stem cell or bone marrow transplantation. There have been significant improvements in transplantation over the last 20 years, which has improved outcomes. These improvements include the ability to use lower doses of chemotherapy to reduce toxicity for patients, as well as strategies to reduce the risk of relapse. I am interested in using new therapies and approaches to improve outcomes after stem cell transplantation for blood cancers. It is important to work together with patients to determine their goals for treatment and select the best path forward. I have enjoyed working with patients and their families for many years after their transplant.
Dr. Alyea is rated as an Experienced provider by MediFind in the treatment of Prolymphocytic Leukemia. His top areas of expertise are Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Transplant.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
2400 Pratt St, Durham, NC 27705
2400 Pratt St, Austell, GA 30106
University Of North Carolina At Chapel Hill
Deborah Stephens is a Hematologist and a Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Stephens is rated as an Elite provider by MediFind in the treatment of Prolymphocytic Leukemia. Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Stephens is currently accepting new patients.
Duke Blood Cancer Center
Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as a Distinguished provider by MediFind in the treatment of Prolymphocytic Leukemia. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Duke Blood Cancer Center
I have over twenty years of experience as a hematologist-oncologist focusing in hematologic malignancies, leukemias, lymphomas, myeloma, and myelodysplastic and myeloproliferative syndromes. My patient care philosophy stresses interactive discussions with patients and their families on what to expect from the illness and treatment options, making sure that all their concerns and questions are addressed. Caring for patients with cancer is complex and my care team is dedicated to helping patients with the family, social, emotional, and financial issues, in addition to compassionate medical care. Dr. Kirby is rated as a Distinguished provider by MediFind in the treatment of Prolymphocytic Leukemia. Her top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Follicular Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Alyea isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Myelodysplastic Syndrome (MDS)Dr. Alyea isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Bone Marrow TransplantDr. Alyea isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid Leukemia
- Chronic B-Cell Leukemia (CBCL)Dr. Alyea isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Alyea isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Anaplastic Large Cell LymphomaDr. Alyea isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- B-Cell LymphomaDr. Alyea isExperienced. Learn about B-Cell Lymphoma.
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Myelomonocytic Leukemia (CMML)
- Classical Hodgkin LymphomaDr. Alyea isExperienced. Learn about Classical Hodgkin Lymphoma.


